While community transmission remains a challenge, we must understand the effects the pandemic is having on younger adults to design effective public health responses and messaging.
Academic rigour, journalistic flair
COVID-19 – Articles, Analysis, Comment
Displaying 301 - 325 of 641 articles
Some quarantine hotels provide more of a ‘holiday vibe’ than others. Some countries don’t use quarantine hotels at all. Others use technology to make sure people stick to the rules.
The early and mid-career researchers who bear most of the teaching and research workload are exhausted and underpaid. Many won’t survive the funding squeeze, but Australia can’t afford to lose them.
The centralised system that made NZ’s initial pandemic response so successful also explains the recent failures at the border.
Some 70-80% of health-care workers testing positive to COVID-19 in Victoria’s second wave were infected at work, compared with 22% in the first wave.
Church leaders have raised concerns over a COVID-19 vaccine produced using cells derived from aborted foetuses. But the Vatican has already ruled such vaccines ‘morally separate’ from the abortions.
This is just one person. Is he the exception? Is he the rule? We don’t know yet for sure. But reinfection is definitely possible.
If you became suddenly unwell, would your family or health team know your wishes? Here’s why advance care planning should be part of Australia’s strategic response to COVID-19.
The government continues to pledge funds for the aged-care sector in the face of COVID-19. But this is damage control rather than what we actually need — a co-ordinated, evidence-based national plan.
When thinking about better uses for temporarily vacant buildings caused by the pandemic, Australia can learn much from the UK.
The traffic light alert system, first proposed in response to the 2003 Beijing SARS outbreak, is already being used around the world to classify travel and inform restrictions in classrooms.
Australian universities face a huge revenue hit from falling international student numbers due to COVID-19 and tensions with China. Some institutions should consider merging rather than downsizing.
Genetic analysis of virus samples from New Zealand’s latest COVID-19 cases is now much swifter. It’s providing key information, but hasn’t yet answered the question of where this second wave started.
The government should used trusted spokespeople, tailor information so it can be understood by different groups, acknowledge people’s concerns, be transparent, and seek public feedback along the way.
Some skin symptoms appear soon after infection, while others arise later or in more severe disease. Most get better with time.
Residential disability care faces many of the same challenges as aged care. Paying close attention to these could help us avert a COVID-19 crisis in Victoria’s disability accommodation.
Some people’s blood can mount an immune response against SARS-CoV-2, even if those blood samples were taken from before the COVID-19 pandemic started.
Most aged care homes are designed to be naturally ventilated. But when windows are closed to keep out the cold, poor ventilation appears to be common – and that’s a problem for infection control.
Here’s what you need to know about the newer COVID-19 test that’s gentler on your nose.
The vaccine hasn’t completed phase 3 trials, so we can’t be sure it will be safe and effective for all. The Australian government’s deal is contingent on these trials being successful.
The problem with hypocrisy is that it shatters truth. If we believe in a principle, but don’t apply it ourselves, that principle is essentially meaningless.
The head lice drug ivermectin is being touted as a coronavirus killer. But studies suggest it would need to be taken in mega-doses far higher than those currently used, with unknown side-effects.
Worried about being accused of virtue signalling or getting funny looks for wearing a mask? Here’s how to test your ethics and come to the right decision.
We can’t change the weather. But understanding how COVID-19 behaves in different conditions can help us respond to the pandemic.
A two-dose coronavirus vaccine would mean we need to produce 12-15 billion doses. This is roughly twice the world’s current total vaccine manufacturing capacity.